Following earlier LabCorp strategic investment, Mission Bio single cell-sequencing technology will be used by LabCorp to support clinical trials and companion diagnostics development, along with the evaluation of potential applications in clinical diagnostics.

Enamine will support Lundbeck’s in-house discovery chemistry competencies with three principal assets enabling Lundbeck to optimally identify and develop hit series in its multiple research programs.

The funding will be used by CytoSMART to further develop its microscopes and to expand its international sales and marketing strategies.

Expanded FluoroType™ MTBDR 2.0 Liquid Array molecular assay with CE-IVD mark provides highly differentiated tuberculosis (TB) detection and antibiotic resistance testing.

New workflows for next-generation 4D metabolomics, leveraging routine, accurate and large-scale collision cross section (CCS) determinations on timsTOF Pro.

AriaDNA real-time qPCR provides fast and easy-to-use microchip-based nucleic acid analysis.

Developing new automation options for QuantiFERON®-TB Gold Plus – the modern blood-based test for TB detection – and new QFT Access for high burden, low-resource regions.

Amazon Filters reports on how a leading Animal Healthcare company has made significant time and cost savings through implementation of a SupaPore 16FPW microfiltration system for bioburden control on its 100m3 batch production of an enzyme added to chicken feed.

A new paradigm in light scattering technology.

Under the terms of the agreement, Domainex will enrich its existing fragment collection with a diverse set of SpiroChem fragments that it will screen with its highly efficient and cost-effective FragmentBuilder platform.